A detailed history of Twinbeech Capital LP transactions in Royalty Pharma PLC stock. As of the latest transaction made, Twinbeech Capital LP holds 182,628 shares of RPRX stock, worth $4.69 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
182,628
Previous 110,709 64.96%
Holding current value
$4.69 Million
Previous $2.92 Million 76.98%
% of portfolio
0.1%
Previous 0.06%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$25.63 - $29.27 $1.84 Million - $2.11 Million
71,919 Added 64.96%
182,628 $5.17 Million
Q2 2024

Aug 14, 2024

BUY
$26.26 - $29.9 $2.91 Million - $3.31 Million
110,709 New
110,709 $2.92 Million
Q4 2023

Feb 14, 2024

BUY
$26.21 - $29.22 $5.35 Million - $5.96 Million
203,959 Added 56.14%
567,250 $15.9 Million
Q3 2023

Nov 14, 2023

SELL
$26.26 - $31.38 $1.22 Million - $1.46 Million
-46,418 Reduced 11.33%
363,291 $9.86 Million
Q2 2023

Aug 14, 2023

BUY
$29.6 - $36.56 $12.1 Million - $15 Million
409,709 New
409,709 $12.6 Million
Q4 2022

Feb 14, 2023

BUY
$39.17 - $44.04 $16.9 Million - $19 Million
430,613 New
430,613 $17 Million
Q2 2022

Aug 15, 2022

SELL
$37.53 - $44.22 $6.71 Million - $7.91 Million
-178,798 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$37.46 - $42.44 $3.49 Million - $3.96 Million
93,200 Added 108.88%
178,798 $6.97 Million
Q4 2021

Feb 14, 2022

BUY
$35.17 - $42.48 $3.01 Million - $3.64 Million
85,598 New
85,598 $3.41 Million
Q3 2021

Nov 15, 2021

SELL
$36.14 - $42.24 $3.73 Million - $4.35 Million
-103,101 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$39.85 - $46.63 $4.11 Million - $4.81 Million
103,101 New
103,101 $4.23 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.